Lawmakers: NIH, FDA bill 'fiscally responsible, meaningful reform'
This article was originally published in Scrip
Executive Summary
Heading into a crucial vote later this week by the full House, the authors of a massive bill aimed at overhauling the US biomedical enterprise – the 21st Century Cures Act – tried to get in front of expected criticism by fiscal conservatives on 6 July by insisting the legislation, which would give the FDA and the National Institutes of Health (NIH) added funding, ultimately would save the nation billions of dollars.